US Stock MarketDetailed Quotes

MRK Merck & Co

Watchlist

95.230
+0.580+0.61%

Close Mar 10 16:00 ET

95.230
0.0000.00%

Pre 07:20 ET

240.55BMarket Cap14.13P/E (TTM)

Merck & Co Stock Forum

hghhjjbj

21 hours ago

$Merck & Co (MRK.US)$

104483282

Mar 4 03:00

Only you are alive 🙏

Share Your Profit/Loss

Justice Bao

Mar 3 07:14

$Merck & Co (MRK.US)$ don"t waste money and invest on this long term is terrible

102735247

Feb 27 21:08

TODAY SUPER DROP TO 70

$Merck & Co (MRK.US)$

hghhjjbj

Feb 27 09:14

$Merck & Co (MRK.US)$ 😎

105362997

Feb 27 08:28

$Merck & Co (MRK.US)$ going up soon today?

AMC Forever

Feb 26 09:26

MRK has longer way to go

$Merck & Co (MRK.US)$ Fair to target at least $100. I left now and moved to $AMC Entertainment (AMC.US)$

Teddy123

Feb 25 05:55

FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

$Merck & Co (MRK.US)$
Can Merck's KEYTRUDA Transform Head and Neck Cancer Treatment After 20-Year Stagnation?

Jessica Amir

Feb 24 17:23

Columns Palantir could fall to $65 before rebounding. Eli Lily is up 14% this year. Alibaba bumps. ASX banks could rebound

With US stocks closing lower for the THIRD day and talk on the street and among institutional investors turning particularly cautious, we need to take note of what’s going on.
As I've been suggesting recently, this sell-off was likely to occur for a couple of key reasons. We’ve had a round of bad news, so we are awaiting good news to break us higher. But traders are bracing for dis...

https://www.youtube.com/watch?v=-odr3Z0SfZ4

From YouTube

Hot tech stocks pull back into the storm, a good opportunity to bottom or a risky trap?

10xStockPicks

Feb 21 07:57

Esperion Therapeutics On The Verge Of Being Acquired, Upside Could Be Over 500% In The Near Future

$Esperion Therapeutics (ESPR.US)$Esperion Therapeutics (ESPR): A High-Growth Opportunity with Potential 10x Returns
Esperion Therapeutics (ESPR), currently trading under $2 per share, has been attracting considerable attention from analysts. Recently, three analysts reaffirmed strong "Buy" ratings, with price targets ranging from $5 to $16 per share. Among the nine analysts covering Esperion, seven h...

No comment yet

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

MRK Merck & Co

Merck & Co Stock Forum

Trending Stocks